Left Ventricular Assist Device
LVAD implant tied to improvement in cerebral blood flow dynamics
PHILADELPHIA — Among patients with advanced HF requiring a left ventricular assist device, measures of cerebrovascular blood flow improved significantly after device implant, a speaker reported.
Aspirin may not be needed in patients with fully magnetically levitated LVAD
PHILADELPHIA — In patients with advanced HF and a fully magnetically levitated left ventricular assist device, avoiding aspirin was safe and reduced bleeding, researchers reported at the American Heart Association Scientific Sessions.
Abiomed recalls LVADs for motor damage risk after contact with TAVR stent
Abiomed announced a recall of its left ventricular assist device due to instructions for use that do not adequately address device use in patients who have undergone transcatheter aortic valve replacement.
Safety of percutaneous microaxial LVAD for cardiogenic shock uncertain vs. other options
For patients presenting with acute MI with cardiogenic shock, the safety of percutaneous microaxial left ventricular assist device use vs. other treatments could not be well established using observational Medicare data, findings show.
Abiomed recalls percutaneous heart pump for cardiogenic shock
Abiomed is recalling specific left ventricular assist device sets used for people with cardiomyopathy due to customer complaints about purge fluid leaking from the sidearm of the pump, according to an FDA press release.
Anemia before, after heart failure device implant common, driving poor survival
Data from a North American registry show anemia can affect more than 75% of candidates for a left ventricular device implant and up to 67% of recipients in the years after implant, driving higher mortality risk and worse quality of life.
Trial of new driver for pediatric VAD could transform research for children with HF
The first prospective FDA-regulated device trial using a pediatric ventricular assist device registry was launched in November. It could transform how research is conducted in children with advanced heart failure.
Adverse events after device implant tied to quality of life measures for end-stage HF
Recent adverse events soon after receiving a left ventricular assist device, such as major organ dysfunction, have the largest effect on scores measuring health-related quality of life, according to a patient registry analysis.
CMS policy change could increase disparities in heart transplant receipt
In 2020, CMS made a policy change to increase access to left ventricular assist devices. It could have unintended consequences in increasing disparities in who receives a heart transplant, according to a research team.
Black patients less likely to receive VADs, heart transplants than white patients
Among adults with advanced HF, Black patients were less likely than white patients to receive a ventricular assist device or a heart transplant, according to the results of the REVIVAL prospective cohort study.